Jun 23, 2016

Posted by in Stock Reports | 0 Comments

Insiders Are Buying These Shares: Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Ares Capital Corporation (NASDAQ:ARCC), Akamai Technologies, Inc. (NASDAQ:AKAM)

Insiders Are Buying These Shares: Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Ares Capital Corporation (NASDAQ:ARCC), Akamai Technologies, Inc. (NASDAQ:AKAM)

 

As a general rule, insider buying shows management’s confidence in the company, and is considered a bullish sign—in other words a sign that stock prices are likely to go up. Conversely, insider selling is considered bearish—those in the know may be off loading their stocks in an expectation that prices will soon fall. So it pays to keep an eye on the activities of insiders.

Studies have shown that prompt and timely dissemination of insider transactions are profitable for investors, as insiders tend to beat the market. The odds in favor of an insider purchase being followed by further purchases are three times greater than the odds of a purchase followed by a sale.

Moving on to the first insider trade June 17, 2016 which involved COELHO PHILIP H, a Director at Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), who acquired 15,000 shares at $0.76 per share to put the total holding at 173,287 shares. Its shares currently owned by company management are 6.70% while institutional investors own about 44.80%. The 6-month change recorded in total insider ownership was 3.85%. On the other side, -12.15% change in total institutional ownership has been reported for the 3-month period.

Ares Capital Corporation (NASDAQ:ARCC) saw an insider buy stock in the company on June 20. BARTLETT STEVE N, Director of the company, bought 200 shares for $14.20 per share worth a total of $7,508. After this insider buying, BARTLETT STEVE now has a total stake of 6,000 shares in the company. Its shares currently owned by company management are 0.40% while institutional investors own about 47.30%. The 6-month change recorded in total insider ownership was 5.11%. On the other side, -4.25% change in total institutional ownership has been reported for the 3-month period.

Akamai Technologies, Inc. (NASDAQ:AKAM) also received some insider trading action as LEIGHTON F THOMSON, who is the company’s Chief Executive Officer of added some 18,881 shares at a price of $52.95 per share to the holding that now comprises of 3,056,034 shares. Its shares currently owned by company management are 0.40% while institutional investors own about 91.60%. The 6-month change recorded in total insider ownership was -10.23%.

Comments are closed.